1. Ludwig DS, Kabat-Zinn J. Mindfulness in medicine. JAMA. 2008;300:1350–1352. [PubMed] 2. Ader R. Much ado about nothing. Adv Mind Body Med. 2001;17:293–295. [PubMed] 3. Anderson JW, Liu C, Kryscio RJ. Blood pressure response to transcendental meditation: a meta-analysis. Am J Hypertens. 2008;21:310–316. [PubMed] 4. Schneider RH, Walton KG, Salerno JW, Nidich SI. Cardiovascular disease prevention and health promotion with the transcendental meditation program and Maharishi consciousness-based health care. Ethn Dis. 2006;16(3 suppl 4):S4–S15. S26. [PMC free article] [PubMed] 5. Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. J Psychosom Res. 2004;57:35–43. [PubMed] 6. Smith JE, Richardson J, Hoffman C, Pilkington K. Mindfulness-based stress reduction as supportive therapy in cancer care: systematic review. J Adv Nurs. 2005;52:315–327. [PubMed] 7. Paul-Labrador M, Polk D, Dwyer JH, et al. Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med. 2006;166:1218–1224. [PubMed] 8. Pagnoni G, Cekic M. Age effects on gray matter volume and attentional performance in Zen meditation. Neurobiol Aging. 2007;28:1623–1627. [PubMed]
9. Wolf DB, Abell N. Examining the effects of meditation techniques on psychosocial functioning. Res Soc Work Pract. 2003;13:27–42.
10. Shannahoff-Khalsa DS. Kundalini Yoga meditation techniques for the treatment of obsessive-compulsive and OC spectrum disorders. Brief Crisis Interv. 2003;3:369–382.
11. Aron A, Aron EN. The transcendental meditation program’s effect on addictive behavior. Addict Behav. 1980;5:3–12. [PubMed]
12. Marlatt GA, Marques JK. Meditation, self-control and alcohol use. In: Stuart RB, editor. Behavioral self-management: strategies, techniques and outcome. New York: Brunner/Mazel; 1977. pp. 117–153.
13. Linehan MM, Comtois KA, Murray AM, et al. Two year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry. 2006;62:1–10. [PubMed] 14. Cahn BR, Polich J. Meditation states and traits: EEG, ERP, and neuroimaging studies. Psychol Bull. 2006;132:180–211. [PubMed] 15. Walsh R, Shapiro SL. The meeting of meditative disciplines and Western psychology: a mutually enriching dialogue. Am Psychol. 2006;61:227–239. [PubMed] 16. Craven JL. Meditation and psychotherapy. Can J Psychiatry. 1989;34:648–653. [PubMed] 17. Young JD, Taylor E. Meditation as a voluntary hypometabolic state of biological activation. News Physiol Sci. 1998;13:149–153. [PubMed] 19. Hankey A. Studies of advanced stages of meditation in the Tibetan Buddhist and Vedic traditions. I: a comparison of general changes. Evid Based Complement Alternat Med. 2006;3:513–521. [PMC free article] [PubMed]
20. Kabat-Zinn J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain and illness. New York: Delacorte; 2000.
21. Cardoso R, de Souza E, Camano L, Leite Jr. Meditation in health: an operational definition. Brain Res Brain Res Protoc. 2004;14:58–60. [PubMed] 22. Kabat-Zinn J. An outpatient program in behavioral medicine for chronic patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen Hosp Psychiatry. 1982;4:33–47. [PubMed]
23. Baer RA. Mindfulness training as a clinical intervention: a conceptual and empirical review. Clin Psychol Sci Pract. 2003;10:125–143.
24. Lazar SW, Rosman IS, Vanget M, et al. Functional brain imaging of mindfulness and mantra-based meditation. Paper presented at the meeting of the Society for Neuroscience; November 2003; New Orleans, LA.
25. Valentine ER, Sweet PLG. Meditation and attention: a comparison of the effects of concentrative and mindfulness meditation on sustained attention. Ment Health Relig Cult. 1999;2:59–70.
26. Kabat-Zinn J. Indra’s net at work: the mainstreaming of Dharma practice in society. In: Watson G, Batchelor S, editors. The psychology of awakening: Buddhism, science and our day-to-day lives. North Beach, ME: Weiser; 2000. pp. 225–249. 2000.
27. Yogi M. The science of being and art of living. New York: Penguin; 1963.
31. Wallace RK, Benson H, Wilson AF. A wakeful hypometabolic physiologic state. Am J Physiol. 1971;221:795–799. [PubMed] 32. Wallace RK. Physiological effects of transcendental meditation. Science. 1970;167:1751–1754. [PubMed] 33. Wallace RK. The physiology of meditation. Sci Am. 1972;226:84–90. [PubMed] 34. Dillbeck MC, Bronson EC. Short-term longitudinal effects of the transcendental meditation technique on EEG power and coherence. Int J Neurosci. 1981;14:147–151. [PubMed]
35. Hebert R, Tan G. Enhanced EEG alpha phase synchrony in practitioners of the transcendental meditation technique. Paper presented at the meeting of the International Society for Neuronal Regulation; April 2004; Winterthur, Switzerland.
36. Travis F, Tecce J, Arenander A, Wallace RK. Patterns of EEG coherence, power, and contingent negative variation characterize the integration of transcendental and waking states. Biol Psychol. 2002;61:293–319. [PubMed] 37. Basar E, Schurmann M, Basar-Eroglu C, Karakas S. Alpha oscillations in brain functioning: an integrative theory. Int J Psychophysiol. 1997;26:5–29. [PubMed] 38. Basar E, Basar-Eroglu C, Karakas S, Schurmann M. Gamma, alpha, delta, and theta oscillations govern cognitive processes. Int J Psychophysiol. 2001;39:241–248. [PubMed] 39. Streeter CC, Jensen JE, Perlmutter RM, et al. Yoga Asana sessions increase brain GABA levels: a pilot study. J Altern Complment Med. 2007;13:419–426. [PubMed] 40. Elias AN, Guich S, Wilson AF, et al. Ketosis with enhanced GABAergic tone promotes physiological changes in transcendental meditation. Med Hypotheses. 2000;54:660–662. [PubMed] 41. Jevning R, Anand R, Biedebach M, Fernando G. Effects on regional cerebral blood flow of transcendental meditation. Physiol Behav. 1996;59:399–402. [PubMed] 42. Maclean CR, Walton KG, Wenneberg SR, et al. Effects of the transcendental meditation program on adaptive mechanisms: changes in hormone levels and responses to stress after 4 months of practice. Psychoneuroendocrinology. 1997;22:277–295. [PubMed] 43. Alexander CN, Langer EJ, Newman RI, Chandler HM, Davies JL, et al. Transcendental meditation, mindfulness, and longevity: an experimental study with the elderly. J Pers Soc Psychol. 1989;57:950–964. [PubMed]
44. Wolf DB, Abell N. Examining the effects of meditation techniques on psychosocial functioning. Res Soc Work Pract. 2003;13:27–42.
45. Raskin M, Bali LR, Peeke HV. Muscle biofeedback and transcendental meditation. A controlled evaluation of efficacy in the treatment of chronic anxiety. Arch Gen Psychiatry. 1980;37:93–97. [PubMed] 46. Canter PH, Ernst E. The cumulative effects of Transcendental Meditation on cognitive function—a systematic review of randomised controlled trials. Wien Klin Wochenschr. 2003;115:758–766. [PubMed]
47. de Bary WT. The Buddhist tradition in India, China and Japan. New York: Vintage; 1972.
48. Ford J. Zen Master Who? A guide to the people and stories of Zen. Somerville, MA: Wisdom; 2006.
49. Echenhofer FG, Coombs MM, Samten L. EEG and P300 differences during meditation and rest in advanced Tibetan Buddhist and beginning meditators. Paper presented at the meeting of the Society for Psychophysical Research; October 1992; San Diego, CA.
50. Faber PL, Lehmann D, Gianotti LRR, Kaelin M, Pascual-Marqui RD. Scalp and intracerebral (LORETA) theta and gamma EEG coherence in meditation. Paper presented at the meeting of the International Society for Neuronal Regulation; April 2004; Winterthur, Switzerland.
51. Dunn BR, Hartigan JA, Mikulas WL. Concentration and mindfulness meditations: unique forms of consciousness? Appl Psychophysiol Biofeedback. 1999;24:147–165. [PubMed]
52. Ritskes R, Ritskes-Hoitinga M, Stodkilde-Jorgensen H, Baerentsen K, Hartman T. MRI scanning during Zen meditation: the picture of enlightenment? Constructivism Hum Sci. 2003;8:85–90.
53. Newberg A, Pourdehnad M, Alavi A, d’Aquili EG. Cerebral blood flow during meditative prayer: preliminary findings and methodological issues. Percept Motor Skills. 2003;97:625–630. [PubMed]
54. Baerentsen KB. Onset of meditation explored with fMRI. Neuroimage. 2001;13:S297.
55. Murata T, Takahashi T, Hamada T, et al. Individual trait anxiety levels characterizing the properties of Zen meditation. Neuropsychobiology. 2004;50:189–194. [PubMed] 56. Lazar SW, Kerr CE, Wasserman RH, et al. Meditation experience is associated with increased cortical thickness. Neuroreport. 2005;16:1893–1897. [PMC free article] [PubMed] 57. Khalsa SS, Rudrauf D, Damasio AR, Davidson RJ, Lutz A, Tranel D. Interoceptive awareness in experienced meditators. Psychophysiology. 2008;45:671–677. [PMC free article] [PubMed] 58. Pagnoni G, Cekic M, Guo Y. ‘Thinking about not-thinking’: neural correlates of conceptual processing during Zen meditation. PLoS ONE. 2008;3 e3083. [PMC free article] [PubMed] 59. Pagnoni G, Cekic M. Age effects on gray matter volume and attentional performance in Zen meditation. Neurobiol Aging. 2007;28:1623–1627. [PubMed] 60. Pace TW, Negi LT, Adame DD, et al. Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology. 2009;34:87–98. [PMC free article] [PubMed] 61. Brefczynski-Lewis JA, Lutz A, Schaefer HS, Levinson DB, Davidson RJ. Neural correlates of attentional expertise in long-term meditation practitioners. Proc Natl Acad Sci U S A. 2007;104:11483–11488. [PubMed]
62. Krisanaprakornkit T, Krisanaprakornkit W, Piyavhatkul N, Laopaiboon M. Meditation therapy for anxiety disorders. Cochrane Database Syst Rev. 2006;(1) CD004998.
63. Disayavanish P. The effect of Buddhist insight meditation on stress and anxiety [PhD dissertation] Illinois State University, Department of Educational Administration and Foundations; 1994.
64. Bowen S, Witkiewitz K, Dillworth TM, et al. Mindfulness meditation and substance use in an incarcerated population. Psychol Addict Behav. 2006;20:343–347. [PubMed]
65. Marlatt GA, Kristeller J. Mindfulness and meditation. In: Miller WR, editor. Integrating spirituality into treatment. Washington, DC: American Psychological Association; 1999. pp. 67–84.
66. Kabat-Zinn J. Wherever you go, there you are: mindfulness meditation in everyday life. New York: Hyperion; 1994.
67. Hanh TN. The miracle of mindfulness. Boston: Beacon; 1976.
68. Hayes SC, Wilson KG. Some applied implications of a contemporary analytic account of verbal events. Behavior Anal. 1993;16:283–301. [PubMed]
69. Hayes SC. Acceptance and change: content and context in psychotherapy. Reno, NV: Context; 1994.
70. Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen Hosp Psychiatry. 1982;4:33–47. [PubMed]
71. Linehan MM. Skills training manual for treating borderline personality disorder. New York: Guilford; 1993.
72. Teasdale JD, Segal Z, Williams JM. How does cognitive therapy prevent depressive relapse and why should attentional control (mindfulness training) help? Behav Res Ther. 1995;33:25–39. [PubMed] 73. Kristeller JL, Hallett CB. An exploratory study of a meditation-based intervention for binge eating disorder. J Health Psychol. 1999;4:357–363. [PubMed] 74. Farb, Segal ZV, Mayberg H. Attending to the present: mindfulness meditation reveals distinct neural modes of self-reference. Soc Cogn Affect Neurosci. 2007;2:313–322. [PMC free article] [PubMed]
75. Baron Short E, Kose S, Mu Q, et al. Regional brain activation during meditation shows time and practice effects: an exploratory fMRI study. Evid Based Complement Alternat Med. 2007 Oct 27; [Epub ahead of print]
76. Ramel W, Goldin PR, Carmona PE, McQuaid JR. The effects of mindfulness meditation on cognitive process and affect in patients with past depression. Cognit Ther Res. 2004;28:433–455.
77. Tacon AM, McComb J, Caldera Y, Randolph P. Mindfulness meditation, anxiety reduction, and heart disease: a pilot study. Fam Community Health. 2003;26:25–33. [PubMed] 78. Oman D, Shapiro SL, Thoresen CE, Plante TG, Flinders T. Meditation lowers stress and supports forgiveness among college students: a randomized controlled trial. J Am Coll Health. 2008;56:569–578. [PubMed] 79. Sephton S, Salmon P, Weissbecker I, et al. Mindfulness meditation alleviates depressive symptoms in women with fibromyalgia: results of a randomized clinical trial. Arthritis Rheum. 2007;57:77–85. [PubMed] 80. Lynch TR, Trost WT, Salsman N, Linehan MM. Dialectical behavior therapy for borderline personality disorder. Annu Rev Clin Psychol. 2007;3:181–205. [PubMed] 81. Dimeff LA, Linehan MM. Dialectical behavior therapy for substance abusers. Addict Sci Clin Pract. 2008;4:39–47. [PMC free article] [PubMed] 82. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol. 2000;68:615–623. [PubMed] 83. Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol. 2004;72:31–40. [PubMed] 84. Williams JM, Teasdale JD, Segal ZV, Soulsby J. Mindfulness-based cognitive therapy reduces overgeneral autobiographical memory in formerly depressed patients. J Abnorm Psychol. 2000;109:150–155. [PubMed] 85. Hoppes K. The application of mindfulness-based cognitive interventions in the treatment of co-occurring addictive and mood disorders. CNS Spectr. 2006;11:829–851. [PubMed] 86. Castillo RJ. Depersonalization and meditation. Psychiatry. 1990;53:158–168. [PubMed] 87. Lazarus AA. Psychiatric problems precipitated by transcendental meditation. Psychol Rep. 1976;39:601–602. [PubMed] 88. Walsh R, Roche L. Precipitation of acute psychotic episodes by intensive meditation in individuals with a history of schizophrenia. Am J Psychiatry. 1979;136:1085–1086. [PubMed] 89. Chan-Ob T, Boonyanaruthee V. Meditation in association with psychosis. J Med Assoc Thai. 1999;82:925–930. [PubMed] 90. Singh NN, Lancioni GE, Winton AS, et al. Individuals with mental illness can control their aggressive behavior through mindfulness training. Behav Modif. 2007;31:313–328. [PubMed] 91. Moreno FA, Wiegand CB, Taitano EK, Delgado PL. Safety, tolerability and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. J Clin Psychiatry. 2006;67:1735–1740. [PubMed] 92. Krupitsky EM, Burakov AM, Dunaevsky IV, Romanova TN, Slavina TY, Grinenko AY. Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence. J Psychoactive Drugs. 2007;39:13–19. [PubMed] 93. Ellison CG, Levin JS. The religion-health connection: evidence, theory and future directions. Health Educ Behav. 1998;25:700–720. [PubMed] 94. Flynn PM, Joe GW, Broome KM. Looking back on cocaine dependence: reasons for recovery. Am J Addict. 2003;12:398–411. [PubMed]
95. Koenig HG, McCullough ME, Larson DB. Handbook of religion and health. Oxford: Oxford University Press; 2001.
96. Miller WR. Researching the spiritual dimensions of alcohol and other drug problems. Addiction. 1998;93:979–990. [PubMed]
97. Miller WR, C’de Baca J. Quantum change: when epiphanies and sudden insights transform ordinary lives. New York: Guilford; 2001.
98. Emmons RA. The psychology of ultimate concerns: motivation and spirituality in personality. New York: Guilford; 1999.
99. Griffiths RR, Richards WA, McCann U, Jesse R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl) 2006;187:268–283. [PubMed]
100. Marlatt GA, Witkiewitz K, Dillworth TM, et al. Vipassana meditation as a treatment for alcohol and drug use disorders. In: Hayes SC, Follette VM, Linehan MM, editors. Mindfulness and acceptance: expanding the cognitive-behavioral tradition. New York: Guilford; 2004. pp. 261–287.
101. Marlatt GA, Donovan DM. Relapse prevention. 2nd ed. New York: Guilford; 2000.